Abstract
Background: An empyema, or empyema thoracis, is a collection of purulent material in the pleural space. The management and presentation varies considerably by managing physician, geographic location, and economic resources. Objectives: The aim of this study was to re‐emphasize the importance of open drainage in the treatment of advanced thoracic empyema and to assess it's effectiveness in patients who did not respond to more conservative treatment like tube thoracostomy and/ or are not fit for major surgical interventions like thoracotomy. Patients and Methods: The current retrospective study was carried out in the Cadiothoracic and Vascular Unit in Ibn- Al-Nafees Teaching Hospital ( Iraq / Baghdad ) & AL-Hussein Teaching Hospital ( Iraq / Thi-Qar ) from April 2009 to February 2017. The number of patients included in the study was (30) patients. Most of our patients were too cachectic to tolerate thoracotomy for decortication or more aggressive treatment. We treated them by open drainage with rib resection.Thoracoplasty was added to some of them. Results: The highest incidence of chronic non-resolving empyema cavity was among patients between (41-60) years old. The commonest type of surgical procedure applied on patients was Elloeser flap whithout thoracoplasty. Certain Co-morbidities could be recognized in patients with chronic empyema cavity like D.M., Hypertension, Ischemic heart disease & Malignancy. The duration after which the open drainage system closes varies widely between the patients depending on several factors like ( size of chronic empyema cavity, the presence of co-morbidities, adherence to antibiotics, the presence of bronchopleural fistula, etc…). Conclusion: The surgical procedure of Modified Elloeser flap was very effective in treatment of chronic empyema cavity in patients who did not respond to more conservative treatment like tube thoracostomy and/ or are not fit for major surgical interventions like thoracotomy. Open drainage should not be ignored as one of the therapeutic options in treatment of advanced thoracic empyema. It might be the best therapeutic modality in cachectic patients where the facilities for more aggressive treatment are not possible.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.